Evidence map›Paper›PMID 37111548›Full record

ArticlePharmaceutics2023

Phenolic Fingerprint, Bioactivity and Nanoformulation of

Maria De Luca, Carlo Ignazio Giovanni Tuberoso, Ramon Pons, María Teresa García, María Del Carmen Morán, Giulio Ferino, Antonio Vassallo, Giuseppe Martelli, Carla Caddeo

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Valorization ofPlants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. The Anti-Angiogenic Effect ofFoods (Basel, Switzerland) · 2025
    Article
  5. Foods (Basel, Switzerland) · 2025
    Article
  6. Biological Effects ofPlants (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Exploring Phenolic Compounds Extraction from Saffron (Molecules (Basel, Switzerland) · 2024
    Article
  12. A Nano-Based Approach to DeliverMolecules (Basel, Switzerland) · 2024
    Article
  13. Antioxidants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria De LucaDepartment of Science, University of Basilicata, Viale dell'Ateneo Lucano 10, 85100 Potenza, Italy.ORCID 0000-0002-7827-7742
Carlo Ignazio Giovanni TuberosoDepartment of Life and Environmental Sciences, University of Cagliari, SS 554-bivio per Sestu, Monserrato, 09042 Cagliari, Italy.ORCID 0000-0002-8097-3333
Ramon PonsDepartment of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), c/Jordi Girona, 18-26, 08034 Barcelona, Spain.ORCID 0000-0003-4273-9084
María Teresa GarcíaDepartment of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), c/Jordi Girona, 18-26, 08034 Barcelona, Spain.ORCID 0000-0001-9967-3472
María Del Carmen MoránDepartment of Biochemistry and Physiology, Physiology Section, Faculty of Pharmacy and Food Science, University of Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.ORCID 0000-0003-2336-9540
Giulio FerinoCeSAR, University of Cagliari, SS 554-Bivio per Sestu, Monserrato, 09042 Cagliari, Italy.
Antonio VassalloDepartment of Science, University of Basilicata, Viale dell'Ateneo Lucano 10, 85100 Potenza, Italy.ORCID 0000-0001-7937-3309
Giuseppe MartelliDepartment of Science, University of Basilicata, Viale dell'Ateneo Lucano 10, 85100 Potenza, Italy.
Carla CaddeoDepartment of Life and Environmental Sciences, University of Cagliari, SS 554-bivio per Sestu, Monserrato, 09042 Cagliari, Italy.

Funding

generalitat de Catalunya 2021 SGR 00507the Spanish Government (AEI) and European Union (FEDER) PID2021-124848OB-I00
6 · The paper itself

Abstract

The nanoformulation of plant extracts in phospholipid vesicles is a promising strategy to exploit the biological properties of natural bioactive substances and overcome drawbacks such as poor aqueous solubility, chemical instability, low skin permeation and retention time, which strongly limit their topical application. In this study,

Indexed as

antibacterialantioxidantbiocompatibilityphenolic compositionphospholipid vesiclesPrunus spinosa berry extractskin delivery

Identifiers

PMID37111548
PMCPMC10144133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.